42 results
8-K
EX-99.1
MRNS
Marinus Pharmaceuticals Inc
18 Mar 22
Marinus Pharmaceuticals Announces FDA Approval of ZTALMY® (ganaxolone) for CDKL5 Deficiency Disorder
5:07pm
when ZTALMY is administered to pregnant women as there are no adequate data on the developmental risk associated with use in pregnant women. In animal
8-K
EX-99.1
MRNS
Marinus Pharmaceuticals Inc
24 Mar 21
Marinus Pharmaceuticals Appoints Dr. Saraswathy (Sara) Nochur
4:09pm
of Women in the Enterprise of Science and Technology (WEST) and is a host and Chair of the Board of Hospitality Homes, a non-profit organization
424B5
0coiqku121049h8e
29 May 20
Prospectus supplement for primary offering
4:14pm
424B5
490zfi9yqwkvlj
28 May 20
Prospectus supplement for primary offering
4:44pm
8-K
EX-99.1
p9pxa
13 Dec 19
Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors
4:16pm
8-K
EX-99.2
1c8sqnc
13 Dec 19
Marinus Pharmaceuticals Appoints Elan Ezickson to Board of Directors
4:16pm
8-K
EX-99.1
lqqfnjd5suzxribqcbcd
13 Dec 19
Marinus Pharmaceuticals Announces PROPOSED Public Offering of Common Stock AND CONCURRENT PRIVATE PLACEMENT
12:00am
424B5
xhoj9er gv
12 Dec 19
Prospectus supplement for primary offering
5:05pm
424B5
0phmkr0
10 Dec 19
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.1
9hupwo9m1l
9 Dec 19
Marinus Presents Additional Data from Ganaxolone Phase 2 Trial in Refractory Status Epilepticus at the American Epilepsy Society Annual Meeting
7:18am
8-K
EX-99.3
au39vcl0910h6
9 Dec 19
Marinus Presents Additional Data from Ganaxolone Phase 2 Trial in Refractory Status Epilepticus at the American Epilepsy Society Annual Meeting
7:18am
8-K
EX-99.1
ztvy v5my9l
8 Nov 19
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter Financial Results
4:03pm
8-K
EX-99.1
m938xps
29 Oct 19
Marinus Pharmaceuticals Appoints Joe Hulihan, M.D., as Chief Medical Officer
1:31pm
8-K
EX-99.2
verjo64e91oxc
26 Sep 19
Other Events
12:05pm
8-K
EX-99.1
y1hi30cc jk6kuf8
8 Aug 19
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter Financial Results
4:34pm